Already approved for Dravet syndrome, fenfluramine (Fintepla) for seizure control in LGS was supported by data from a global, randomized, placebo-controlled phase 3 clinical trial.
FDA Approves UCB's Fintepla to Treat Seizures Associated with Lennox-Gastaut Syndrome globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
FINTEPLA® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle.
/PRNewswire/ The Lennox-Gastaut Syndrome (LGS) Foundation debuts new Cure LGS 365 Research Grants Program. On Rare Disease Day, the Lennox-Gastaut Syndrome.
LGS Foundation Launches Novel Scientific Research Grant Program globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.